All In MedTech

Device Trial Radar · NCT06634719

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)

A Prospective Multicenter Safety and Feasibility Study of the Juveena Hydrogel System for Use for Temporary Control of Chronic Ovulatory Heavy Menstrual Bleeding (HMB)

Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

13

Actual

Start

Feb 1, 2025

Primary completion

Apr 22, 2026

Study completion May 22, 2026

Sponsor

Lead sponsor
Rejoni Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 10, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multicenter, single-arm interventional feasibility study to evaluate the safety and feasibility of the Juveena Hydrogel System for temporary control of heavy menstrual bleeding (HMB) in women with a history of chronic ovulatory HMB.

Conditions

  • Heavy Menstrual Bleeding

Interventions

  • Juveena Hydrogel SystemDevice

    The Juveena Hydrogel System is a single-use device that is instilled into the endometrial cavity as a liquid and sets up as a gel intrauterine tamponade within seconds.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Effectiveness EndpointTime frame: Within 7 days post-treatment

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Applied Research Center of Arkansas

    Little Rock, Arkansas

  • Rubino OB/GYN (Axia Women's Health)

    West Orange, New Jersey

  • Seven Hills Clinical Research Group, LLC

    Cincinnati, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.